Transaction #11244 · Form 4 · 0000064803-25-000065
CVS HEALTH Corp · Stock award · Deferred Stock Units
CVS HEALTH Corp · Transacted November 20, 2025 · Filed November 21, 2025
What does this filing report?
An SEC Form 4 filing for CVS HEALTH Corp records a stock award involving Deferred Stock Units on November 20, 2025. The reported quantity was 2,202.788. The filing date is November 21, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- CVS HEALTH Corp
- Company CIK
- 0000064803
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 2,202.788
- Reported price
- 76.04
- Reference value
- 167,499.99952
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 8,080.2915
- Ownership description
- Not reported
- SEC acceptance time
- Nov 21, 2025, 5:45 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- ROBBINS LARRY ↗
Director
CIK 0001228603
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 2,202.788
- Conversion / exercise price
- 0
- Exercise date
- Not reported
- Expiration date
- Not reported
Filing footnotes & remarks
- F1
- Consists of deferred stock units issued for deferral of a semi-annual retainer in connection with the Issuer's non-employee director compensation policy, valued at the market price, pursuant to the Issuer's 2017 Incentive Compensation Plan.
- F2
- Consists of deferred stock units, each to be converted into one share of common stock and issued upon the Reporting Person's retirement from the Issuer's Board of Directors, as elected by the Reporting Person.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.